Calorie Restriction mimicking Longevity drug could be available in 5 years
Sirtris’ resveratrol formulation is now in Phase II clinical trials for diabetes. When it hits the market in four or five hears, David Sinclair [co-founder of Sirtris Pharmaceuticals, discovered the molecule resveratrol. Sirtis Pharmaceuticals was bought by GlaxoSmithKline for $720 million] said, “It’ll be on the market as a diabetes drug. It’ll have to sell …